TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $54,984,000 | +81.6% | 3,123,107 | 0.0% | 4.40% | +57.6% |
| Q2 2021 | $30,275,000 | -9.4% | 3,123,107 | 0.0% | 2.79% | +4.2% |
| Q1 2021 | $33,419,000 | -25.5% | 3,123,107 | +2.3% | 2.68% | -22.5% |
| Q4 2020 | $44,879,000 | +13.5% | 3,053,107 | +9.5% | 3.46% | -2.7% |
| Q3 2020 | $39,555,000 | +77.5% | 2,788,443 | +1.2% | 3.55% | +81.5% |
| Q2 2020 | $22,288,000 | +133.3% | 2,755,000 | +12.7% | 1.96% | +80.7% |
| Q1 2020 | $9,552,000 | – | 2,443,809 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|